Cargando...
The importance of aggressive lipid management in patients at risk: Evidence from recent clinical trials
Clinical trials that evaluate more aggressive cholesterol reduction in a broader range of patients at high risk for coronary heart disease (CHD) are needed to fill gaps in our understanding of the impact of lipid‐lowering therapy on risks for clinical events and mortality. This paper briefly reviews...
Gardado en:
| Publicado en: | Clin Cardiol |
|---|---|
| Autor Principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Wiley Periodicals, Inc.
2007
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6654329/ https://ncbi.nlm.nih.gov/pubmed/15239486 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.4960271505 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|